Abstract
HUMAN insulin differs from porcine insulin by a single amino acid (Thr instead of Ala) at the C-terminal residue of the B-chain. Inouye et al.1 have established a procedure for the semi-synthesis of human insulin, in which trypsin is used as a catalyst for the coupling of desoctapeptide-(B23–B30)-insulin (DOI) with a synthetic octapeptide corresponding to positions B23–B30 of human insulin. DOI was prepared by tryptic digestion of porcine insulin. The enzymatic method has many advantages, in particular, better yields and simple operation, over the chemical methods originally used by Ruttenberg2 and Obermeier and Geiger3. Here we report a more simple and economical method for the semi-synthesis, in which trypsin can catalyse the coupling between desalanine-B30-insulin (DAI) and Thr-OBut to generate human insulin in good yield.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Inouye, K. et al., J. Am. chem. Soc. 101, 751–752 (1979).
Ruttenberg, M. A. Science 177, 623–626 (1972).
Obermeier, R. & Geiger, R. Hoppe-Seyler's Z. physiol. Chem. 357, 759–767 (1976).
Schmitt, E. W. & Gattner, H. G. Hoppe-Seyler's Z. Physiol. Chem. 359, 799–802 (1978).
Oka, T. & Morihara, K. J. Biochem. (Tokyo) 84, 1277–1283 (1978).
Homandberg, G. A., Mattis, J. A. & Laskowski, M. Jr Biochemistry 17, 5220–5227 (1978).
Bromer, W. W. & Chance, R. E. Biochim. biophys. Acta 133, 219–223 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MORIHARA, K., OKA, T. & TSUZUKI, H. Semi-synthesis of human insulin by trypsin-catalysed replacement of Ala-B30 by Thr in porcine insulin. Nature 280, 412–413 (1979). https://doi.org/10.1038/280412a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/280412a0
This article is cited by
-
Therapeutic insulins and their large-scale manufacture
Applied Microbiology and Biotechnology (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.